Recent Quarter Total Invested
$1.69 B
Recent Quarter Institutional Ownership Percentage
121.01%
Total Invested of Last Quarter
$1.85 B
Ownership Percentage of Last Quarter
123.2%
Akero Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TD ASSET MANAGEMENT INC | 08/02/2024 | 154,592 | $3.63 M | 23.68% | 0.26% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 169,591 | $3.98 M | -78.60% | 0.29% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 174,903 | $4.10 M | 20.74% | 0.29% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 08/14/2024 | 193,836 | $4.55 M | 100.00% | 0.33% |
| ABRDN PLC | 08/09/2024 | 199,237 | $4.67 M | 0.00% | 0.34% |
| WOODLINE PARTNERS LP | 08/14/2024 | 200,432 | $4.70 M | 56.05% | 0.34% |
| RHEOS CAPITAL WORKS INC. | 07/24/2024 | 216,000 | $5.07 M | 100.00% | 0.36% |
| ENSIGN PEAK ADVISORS, INC | 08/13/2024 | 237,494 | $5.57 M | 2.13% | 0.40% |
| SIMPLIFY ASSET MANAGEMENT INC. | 08/12/2024 | 245,487 | $5.76 M | -0.08% | 0.41% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 08/12/2024 | 246,463 | $5.78 M | 44.17% | 0.42% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 251,234 | $5.89 M | 32.76% | 0.42% |
| JANE STREET GROUP, LLC | 08/15/2024 | 257,534 | $6.04 M | 2.98% | 0.43% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 262,230 | $6.15 M | -38.43% | 0.44% |
| OCTAGON CAPITAL ADVISORS LP | 08/14/2024 | 283,372 | $6.65 M | -16.66% | 0.48% |
| D. E. SHAW & CO., INC. | 08/14/2024 | 315,717 | $7.41 M | -22.45% | 0.53% |
| DEUTSCHE BANK AG\ | 08/14/2024 | 326,047 | $7.65 M | -0.22% | 0.55% |
| PROPEL BIO MANAGEMENT, LLC | 08/12/2024 | 327,752 | $7.69 M | 0.00% | 0.55% |
| BIOIMPACT CAPITAL LLC | 08/14/2024 | 385,990 | $9.06 M | 15.94% | 0.65% |
| CITADEL ADVISORS LLC | 08/14/2024 | 395,117 | $9.27 M | -5.85% | 0.67% |
| UNIVERSITY OF WISCONSIN FOUNDATION | 08/14/2024 | 423,849 | $9.94 M | 13.76% | 0.71% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 08/06/2024 | 424,901 | $9.97 M | 0.00% | 0.72% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 441,794 | $10.36 M | -36.50% | 0.74% |
| EMERALD ADVISERS, LLC | 08/06/2024 | 515,252 | $12.09 M | -4.38% | 0.87% |
| JPMORGAN CHASE & CO | 08/12/2024 | 542,267 | $12.72 M | 66.65% | 0.91% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 554,865 | $13.02 M | 7.06% | 0.94% |
| NORTHERN TRUST CORP | 08/14/2024 | 587,866 | $13.79 M | -1.64% | 0.99% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 08/14/2024 | 625,087 | $14.66 M | 56.29% | 1.05% |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 08/14/2024 | 719,604 | $16.88 M | 118.99% | 1.21% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 782,950 | $18.37 M | 32.74% | 1.32% |
| LOGOS GLOBAL MANAGEMENT LP | 08/27/2024 | 800,000 | $18.77 M | 0.00% | 1.35% |
| MORGAN STANLEY | 08/14/2024 | 946,528 | $22.21 M | 134.37% | 1.60% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2024 | 1.07 M | $25.20 M | -17.36% | 1.81% |
| BRAIDWELL LP | 08/14/2024 | 1.08 M | $25.44 M | 100.00% | 1.83% |
| BAKER BROS. ADVISORS LP | 08/14/2024 | 1.10 M | $25.74 M | -59.57% | 1.85% |
| YIHENG CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 1.43 M | $33.65 M | 0.00% | 2.42% |
| PERCEPTIVE ADVISORS LLC | 08/16/2024 | 1.50 M | $35.19 M | 8.10% | 2.53% |
| REDMILE GROUP, LLC | 08/14/2024 | 1.61 M | $37.88 M | -13.14% | 2.72% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.62 M | $37.99 M | 14.07% | 2.73% |
| BOXER CAPITAL, LLC | 08/14/2024 | 1.68 M | $39.34 M | 0.00% | 2.83% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2024 | 1.77 M | $41.46 M | 60.36% | 2.98% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2024 | 1.91 M | $44.76 M | 17.68% | 3.22% |
| STATE STREET CORP | 08/14/2024 | 2.69 M | $63.09 M | -29.18% | 4.53% |
| ALKEON CAPITAL MANAGEMENT LLC | 08/14/2024 | 3.33 M | $78.06 M | 0.00% | 5.61% |
| VANGUARD GROUP INC | 08/13/2024 | 3.71 M | $86.92 M | 0.96% | 6.25% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 4.15 M | $97.28 M | 2.11% | 6.99% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 5.11 M | $119.99 M | -1.89% | 8.62% |
| GENERAL ATLANTIC, L.P. | 08/14/2024 | 5.23 M | $122.79 M | 0.00% | 8.83% |
| RTW INVESTMENTS, LP | 08/14/2024 | 5.43 M | $127.43 M | 0.00% | 9.16% |
| BLACKROCK INC. | 08/13/2024 | 5.59 M | $131.06 M | 14.19% | 9.42% |
| JANUS HENDERSON GROUP PLC | 08/14/2024 | 6.88 M | $161.28 M | 12.32% | 11.59% |
Akero Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of AKRO shares?
During the previous two years, 206 institutional investors and hedge funds held shares of Akero Therapeutics, Inc.. The most heavily invested institutionals were:
JANUS HENDERSON GROUP PLC: 6.88 M
BlackRock Inc.: 5.59 M
RTW INVESTMENTS, LP: 5.43 M
GENERAL ATLANTIC, L.P.: 5.23 M
WELLINGTON MANAGEMENT GROUP LLP: 5.11 M
PRICE T ROWE ASSOCIATES INC /MD/: 4.15 M
-
What percentage of Akero Therapeutics, Inc. stock is owned by institutional investors?
121.01% of Akero Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at AKRO ?
Institutional investors have bought a total of 79.20 M shares in the last 24 months. This purchase volume represents approximately $2.27 B in transactions.